Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Branded vs. generic U.S. drug prescriptions dispensed 2005-2018

Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2018

by Matej Mikulic, last edited Sep 12, 2019
Branded vs. generic U.S. drug prescriptions dispensed 2005-2018 The proportion of branded vs. generic drug prescription dispensed in the U.S. has decreased since 2005. In 2005, some 40 percent of prescriptions dispensed were brand name drugs and around 50 percent of drugs dispensed were unbranded generic drugs. For comparison, in 2018, only 10 percent of prescriptions were brand-name drugs while over 85 percent were unbranded generic drugs.
What are generics?

Generic medications are drugs created with the same ingredients as brand-name drugs, but are not created under the umbrella of a brand. They are made to work exactly the same way that brand-name drugs work but are often cheaper. The top generic drug companies in the U.S. include Teva, Mylan and Novartis. Generic drugs provide a large proportion of all pharmaceuticals dispensed. Among all pharmaceutical products dispensed in the U.S., levothyroxine, a drug used to treat hypothyroidism, was the top drug based on number of prescriptions dispensed.

Cost savings through generics

Generic drugs provide an immense amount of savings for consumers in the U.S. The amount of money saved by the U.S. health system through generic usage has more than doubled since 2008. Direct savings for consumers depends on the payer. Commercial insurance coverage had the highest degree of cost savings in the U.S. and those that paid out-of-pocket had the lowest savings as of 2017. However, branded drugs still account for almost three quarters of total U.S. pharmaceutical market revenues.
Show more

Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2018

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
U.S. pharmaceutical industry
U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "U.S. pharmaceutical industry"
  • Contribution to global pharma
  • Overview
  • Companies
  • Research and development
  • Generics
  • Outlook
  • The consumer's view
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $588 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.